Showing results (261-270 of 618) with videos related to
Sort By:
Pageof 62
Neuro-Oncology|November 25, 2024
Canonical amplifications and CDKN2A/B loss refine IDH1/2-mutant astrocytoma prognosisHia S Ghosh, Ruchit V Patel, Elizabeth B Claus, et al.Cancer Chemotherapy and Pharmacology|August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium studyMichael D Prados, W K A Yung, Patrick Y Wen, et al.Cancer Chemotherapy and Pharmacology|November 1, 2011
Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trialDavid A Reardon, Patrick Y Wen, W K Alfred Yung, et al.Current Oncology (Toronto, Ont.)|October 28, 2025
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory GlioblastomaAnna F Piotrowski, Kent Shih, Pierre Giglio, et al.Neuro-Oncology|August 6, 2024
Targeted radionuclide therapy for gliomas: Emerging clinical trial landscapeMichael Weller, Nathalie L Albert, Norbert Galldiks, et al.Neurology|September 2, 2018
PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade gliomaSylvia C Kurz, Lais P Cabrera, David Hastie, et al.Diagnostic Pathology|January 29, 2016
Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in GlioblastomaPhedias Diamandis, Ruben Ferrer-Luna, Raymond Y Huang, et al.Journal of Neuro-Oncology|April 15, 2025
Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosisNarmeen S Rashid, Nayan Lamba, Paul J Catalano, et al.Neuro-Oncology|June 4, 2016
Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumabKen Chang, Biqi Zhang, Xiaotao Guo, et al.Cell Reports|September 30, 2020
Divergent Roles of PI3K Isoforms in PTEN-Deficient GlioblastomasShaozhen Xie, Jing Ni, J Ricardo McFaline-Figueroa, et al.Pageof 62